![Global Nifedipine Controlled-release Tablets Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030](https://www.globalinforesearch.com/uploads/reports-list/report.png)
Global Nifedipine Controlled-release Tablets Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 94
Published Date: 29 Jul 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
![btl](/_nuxt/img/btl.804ba4b.webp)
Description
Nifedipine controlled-release tablets are a type of medication used primarily to treat high blood pressure(hypertension)and certain types of chest pain(angina).Nifedipine belongs to a class of drugs known as calcium channel blockers.These tablets are formulated to release the medication slowly over time,which helps maintain a steady level of the drug in the body and can prolong its therapeutic effect.
According to our (Global Info Research) latest study, the global Nifedipine Controlled-release Tablets market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Nifedipine Controlled-release Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Nifedipine Controlled-release Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Nifedipine Controlled-release Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Nifedipine Controlled-release Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Nifedipine Controlled-release Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nifedipine Controlled-release Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nifedipine Controlled-release Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Shanghai Shyndec Pharma, Simcere, Qingdao Baiyang Pharmaceutical, China Resources Double Crane Limin Pharmaceutical (Jinan), Hefei Cube Pharma, Deyao Pharma, Apichope, Nanjing EASEHEAL Pharma, Beijing Honglin Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Nifedipine Controlled-release Tablets market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Generic Drug
Original Drug
Market segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Major players covered
Bayer
Shanghai Shyndec Pharma
Simcere
Qingdao Baiyang Pharmaceutical
China Resources Double Crane Limin Pharmaceutical (Jinan)
Hefei Cube Pharma
Deyao Pharma
Apichope
Nanjing EASEHEAL Pharma
Beijing Honglin Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nifedipine Controlled-release Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nifedipine Controlled-release Tablets, with price, sales quantity, revenue, and global market share of Nifedipine Controlled-release Tablets from 2019 to 2024.
Chapter 3, the Nifedipine Controlled-release Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nifedipine Controlled-release Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Nifedipine Controlled-release Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nifedipine Controlled-release Tablets.
Chapter 14 and 15, to describe Nifedipine Controlled-release Tablets sales channel, distributors, customers, research findings and conclusion.
![btl](/_nuxt/img/btl.804ba4b.webp)
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Nifedipine Controlled-release Tablets Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Generic Drug
1.3.3 Original Drug
1.4 Market Analysis by Application
1.4.1 Overview: Global Nifedipine Controlled-release Tablets Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital and Clinic
1.4.3 Retail Pharmacies
1.4.4 Other
1.5 Global Nifedipine Controlled-release Tablets Market Size & Forecast
1.5.1 Global Nifedipine Controlled-release Tablets Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Nifedipine Controlled-release Tablets Sales Quantity (2019-2030)
1.5.3 Global Nifedipine Controlled-release Tablets Average Price (2019-2030)2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Nifedipine Controlled-release Tablets Product and Services
2.1.4 Bayer Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bayer Recent Developments/Updates
2.2 Shanghai Shyndec Pharma
2.2.1 Shanghai Shyndec Pharma Details
2.2.2 Shanghai Shyndec Pharma Major Business
2.2.3 Shanghai Shyndec Pharma Nifedipine Controlled-release Tablets Product and Services
2.2.4 Shanghai Shyndec Pharma Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Shanghai Shyndec Pharma Recent Developments/Updates
2.3 Simcere
2.3.1 Simcere Details
2.3.2 Simcere Major Business
2.3.3 Simcere Nifedipine Controlled-release Tablets Product and Services
2.3.4 Simcere Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Simcere Recent Developments/Updates
2.4 Qingdao Baiyang Pharmaceutical
2.4.1 Qingdao Baiyang Pharmaceutical Details
2.4.2 Qingdao Baiyang Pharmaceutical Major Business
2.4.3 Qingdao Baiyang Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
2.4.4 Qingdao Baiyang Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Qingdao Baiyang Pharmaceutical Recent Developments/Updates
2.5 China Resources Double Crane Limin Pharmaceutical (Jinan)
2.5.1 China Resources Double Crane Limin Pharmaceutical (Jinan) Details
2.5.2 China Resources Double Crane Limin Pharmaceutical (Jinan) Major Business
2.5.3 China Resources Double Crane Limin Pharmaceutical (Jinan) Nifedipine Controlled-release Tablets Product and Services
2.5.4 China Resources Double Crane Limin Pharmaceutical (Jinan) Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 China Resources Double Crane Limin Pharmaceutical (Jinan) Recent Developments/Updates
2.6 Hefei Cube Pharma
2.6.1 Hefei Cube Pharma Details
2.6.2 Hefei Cube Pharma Major Business
2.6.3 Hefei Cube Pharma Nifedipine Controlled-release Tablets Product and Services
2.6.4 Hefei Cube Pharma Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Hefei Cube Pharma Recent Developments/Updates
2.7 Deyao Pharma
2.7.1 Deyao Pharma Details
2.7.2 Deyao Pharma Major Business
2.7.3 Deyao Pharma Nifedipine Controlled-release Tablets Product and Services
2.7.4 Deyao Pharma Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Deyao Pharma Recent Developments/Updates
2.8 Apichope
2.8.1 Apichope Details
2.8.2 Apichope Major Business
2.8.3 Apichope Nifedipine Controlled-release Tablets Product and Services
2.8.4 Apichope Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Apichope Recent Developments/Updates
2.9 Nanjing EASEHEAL Pharma
2.9.1 Nanjing EASEHEAL Pharma Details
2.9.2 Nanjing EASEHEAL Pharma Major Business
2.9.3 Nanjing EASEHEAL Pharma Nifedipine Controlled-release Tablets Product and Services
2.9.4 Nanjing EASEHEAL Pharma Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Nanjing EASEHEAL Pharma Recent Developments/Updates
2.10 Beijing Honglin Pharma
2.10.1 Beijing Honglin Pharma Details
2.10.2 Beijing Honglin Pharma Major Business
2.10.3 Beijing Honglin Pharma Nifedipine Controlled-release Tablets Product and Services
2.10.4 Beijing Honglin Pharma Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Beijing Honglin Pharma Recent Developments/Updates3 Competitive Environment: Nifedipine Controlled-release Tablets by Manufacturer
3.1 Global Nifedipine Controlled-release Tablets Sales Quantity by Manufacturer (2019-2024)
3.2 Global Nifedipine Controlled-release Tablets Revenue by Manufacturer (2019-2024)
3.3 Global Nifedipine Controlled-release Tablets Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Nifedipine Controlled-release Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Nifedipine Controlled-release Tablets Manufacturer Market Share in 2023
3.4.3 Top 6 Nifedipine Controlled-release Tablets Manufacturer Market Share in 2023
3.5 Nifedipine Controlled-release Tablets Market: Overall Company Footprint Analysis
3.5.1 Nifedipine Controlled-release Tablets Market: Region Footprint
3.5.2 Nifedipine Controlled-release Tablets Market: Company Product Type Footprint
3.5.3 Nifedipine Controlled-release Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations4 Consumption Analysis by Region
4.1 Global Nifedipine Controlled-release Tablets Market Size by Region
4.1.1 Global Nifedipine Controlled-release Tablets Sales Quantity by Region (2019-2030)
4.1.2 Global Nifedipine Controlled-release Tablets Consumption Value by Region (2019-2030)
4.1.3 Global Nifedipine Controlled-release Tablets Average Price by Region (2019-2030)
4.2 North America Nifedipine Controlled-release Tablets Consumption Value (2019-2030)
4.3 Europe Nifedipine Controlled-release Tablets Consumption Value (2019-2030)
4.4 Asia-Pacific Nifedipine Controlled-release Tablets Consumption Value (2019-2030)
4.5 South America Nifedipine Controlled-release Tablets Consumption Value (2019-2030)
4.6 Middle East & Africa Nifedipine Controlled-release Tablets Consumption Value (2019-2030)5 Market Segment by Type
5.1 Global Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2030)
5.2 Global Nifedipine Controlled-release Tablets Consumption Value by Type (2019-2030)
5.3 Global Nifedipine Controlled-release Tablets Average Price by Type (2019-2030)6 Market Segment by Application
6.1 Global Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2030)
6.2 Global Nifedipine Controlled-release Tablets Consumption Value by Application (2019-2030)
6.3 Global Nifedipine Controlled-release Tablets Average Price by Application (2019-2030)7 North America
7.1 North America Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2030)
7.2 North America Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2030)
7.3 North America Nifedipine Controlled-release Tablets Market Size by Country
7.3.1 North America Nifedipine Controlled-release Tablets Sales Quantity by Country (2019-2030)
7.3.2 North America Nifedipine Controlled-release Tablets Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)8 Europe
8.1 Europe Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2030)
8.2 Europe Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2030)
8.3 Europe Nifedipine Controlled-release Tablets Market Size by Country
8.3.1 Europe Nifedipine Controlled-release Tablets Sales Quantity by Country (2019-2030)
8.3.2 Europe Nifedipine Controlled-release Tablets Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)9 Asia-Pacific
9.1 Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Nifedipine Controlled-release Tablets Market Size by Region
9.3.1 Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Nifedipine Controlled-release Tablets Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)10 South America
10.1 South America Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2030)
10.2 South America Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2030)
10.3 South America Nifedipine Controlled-release Tablets Market Size by Country
10.3.1 South America Nifedipine Controlled-release Tablets Sales Quantity by Country (2019-2030)
10.3.2 South America Nifedipine Controlled-release Tablets Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)11 Middle East & Africa
11.1 Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Nifedipine Controlled-release Tablets Market Size by Country
11.3.1 Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Nifedipine Controlled-release Tablets Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)12 Market Dynamics
12.1 Nifedipine Controlled-release Tablets Market Drivers
12.2 Nifedipine Controlled-release Tablets Market Restraints
12.3 Nifedipine Controlled-release Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry13 Raw Material and Industry Chain
13.1 Raw Material of Nifedipine Controlled-release Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Nifedipine Controlled-release Tablets
13.3 Nifedipine Controlled-release Tablets Production Process
13.4 Industry Value Chain Analysis14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Nifedipine Controlled-release Tablets Typical Distributors
14.3 Nifedipine Controlled-release Tablets Typical Customers15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
![btl](/_nuxt/img/btl.804ba4b.webp)
Table of Figures
List of Tables
Table 1. Global Nifedipine Controlled-release Tablets Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Nifedipine Controlled-release Tablets Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Nifedipine Controlled-release Tablets Product and Services
Table 6. Bayer Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Bayer Recent Developments/Updates
Table 8. Shanghai Shyndec Pharma Basic Information, Manufacturing Base and Competitors
Table 9. Shanghai Shyndec Pharma Major Business
Table 10. Shanghai Shyndec Pharma Nifedipine Controlled-release Tablets Product and Services
Table 11. Shanghai Shyndec Pharma Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Shanghai Shyndec Pharma Recent Developments/Updates
Table 13. Simcere Basic Information, Manufacturing Base and Competitors
Table 14. Simcere Major Business
Table 15. Simcere Nifedipine Controlled-release Tablets Product and Services
Table 16. Simcere Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Simcere Recent Developments/Updates
Table 18. Qingdao Baiyang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Qingdao Baiyang Pharmaceutical Major Business
Table 20. Qingdao Baiyang Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
Table 21. Qingdao Baiyang Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Qingdao Baiyang Pharmaceutical Recent Developments/Updates
Table 23. China Resources Double Crane Limin Pharmaceutical (Jinan) Basic Information, Manufacturing Base and Competitors
Table 24. China Resources Double Crane Limin Pharmaceutical (Jinan) Major Business
Table 25. China Resources Double Crane Limin Pharmaceutical (Jinan) Nifedipine Controlled-release Tablets Product and Services
Table 26. China Resources Double Crane Limin Pharmaceutical (Jinan) Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. China Resources Double Crane Limin Pharmaceutical (Jinan) Recent Developments/Updates
Table 28. Hefei Cube Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Hefei Cube Pharma Major Business
Table 30. Hefei Cube Pharma Nifedipine Controlled-release Tablets Product and Services
Table 31. Hefei Cube Pharma Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Hefei Cube Pharma Recent Developments/Updates
Table 33. Deyao Pharma Basic Information, Manufacturing Base and Competitors
Table 34. Deyao Pharma Major Business
Table 35. Deyao Pharma Nifedipine Controlled-release Tablets Product and Services
Table 36. Deyao Pharma Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Deyao Pharma Recent Developments/Updates
Table 38. Apichope Basic Information, Manufacturing Base and Competitors
Table 39. Apichope Major Business
Table 40. Apichope Nifedipine Controlled-release Tablets Product and Services
Table 41. Apichope Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Apichope Recent Developments/Updates
Table 43. Nanjing EASEHEAL Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Nanjing EASEHEAL Pharma Major Business
Table 45. Nanjing EASEHEAL Pharma Nifedipine Controlled-release Tablets Product and Services
Table 46. Nanjing EASEHEAL Pharma Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Nanjing EASEHEAL Pharma Recent Developments/Updates
Table 48. Beijing Honglin Pharma Basic Information, Manufacturing Base and Competitors
Table 49. Beijing Honglin Pharma Major Business
Table 50. Beijing Honglin Pharma Nifedipine Controlled-release Tablets Product and Services
Table 51. Beijing Honglin Pharma Nifedipine Controlled-release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Beijing Honglin Pharma Recent Developments/Updates
Table 53. Global Nifedipine Controlled-release Tablets Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global Nifedipine Controlled-release Tablets Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Nifedipine Controlled-release Tablets Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 56. Market Position of Manufacturers in Nifedipine Controlled-release Tablets, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 57. Head Office and Nifedipine Controlled-release Tablets Production Site of Key Manufacturer
Table 58. Nifedipine Controlled-release Tablets Market: Company Product Type Footprint
Table 59. Nifedipine Controlled-release Tablets Market: Company Product Application Footprint
Table 60. Nifedipine Controlled-release Tablets New Market Entrants and Barriers to Market Entry
Table 61. Nifedipine Controlled-release Tablets Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Nifedipine Controlled-release Tablets Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 63. Global Nifedipine Controlled-release Tablets Sales Quantity by Region (2019-2024) & (K Units)
Table 64. Global Nifedipine Controlled-release Tablets Sales Quantity by Region (2025-2030) & (K Units)
Table 65. Global Nifedipine Controlled-release Tablets Consumption Value by Region (2019-2024) & (USD Million)
Table 66. Global Nifedipine Controlled-release Tablets Consumption Value by Region (2025-2030) & (USD Million)
Table 67. Global Nifedipine Controlled-release Tablets Average Price by Region (2019-2024) & (US$/Unit)
Table 68. Global Nifedipine Controlled-release Tablets Average Price by Region (2025-2030) & (US$/Unit)
Table 69. Global Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2024) & (K Units)
Table 70. Global Nifedipine Controlled-release Tablets Sales Quantity by Type (2025-2030) & (K Units)
Table 71. Global Nifedipine Controlled-release Tablets Consumption Value by Type (2019-2024) & (USD Million)
Table 72. Global Nifedipine Controlled-release Tablets Consumption Value by Type (2025-2030) & (USD Million)
Table 73. Global Nifedipine Controlled-release Tablets Average Price by Type (2019-2024) & (US$/Unit)
Table 74. Global Nifedipine Controlled-release Tablets Average Price by Type (2025-2030) & (US$/Unit)
Table 75. Global Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2024) & (K Units)
Table 76. Global Nifedipine Controlled-release Tablets Sales Quantity by Application (2025-2030) & (K Units)
Table 77. Global Nifedipine Controlled-release Tablets Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Global Nifedipine Controlled-release Tablets Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Global Nifedipine Controlled-release Tablets Average Price by Application (2019-2024) & (US$/Unit)
Table 80. Global Nifedipine Controlled-release Tablets Average Price by Application (2025-2030) & (US$/Unit)
Table 81. North America Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2024) & (K Units)
Table 82. North America Nifedipine Controlled-release Tablets Sales Quantity by Type (2025-2030) & (K Units)
Table 83. North America Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2024) & (K Units)
Table 84. North America Nifedipine Controlled-release Tablets Sales Quantity by Application (2025-2030) & (K Units)
Table 85. North America Nifedipine Controlled-release Tablets Sales Quantity by Country (2019-2024) & (K Units)
Table 86. North America Nifedipine Controlled-release Tablets Sales Quantity by Country (2025-2030) & (K Units)
Table 87. North America Nifedipine Controlled-release Tablets Consumption Value by Country (2019-2024) & (USD Million)
Table 88. North America Nifedipine Controlled-release Tablets Consumption Value by Country (2025-2030) & (USD Million)
Table 89. Europe Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2024) & (K Units)
Table 90. Europe Nifedipine Controlled-release Tablets Sales Quantity by Type (2025-2030) & (K Units)
Table 91. Europe Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2024) & (K Units)
Table 92. Europe Nifedipine Controlled-release Tablets Sales Quantity by Application (2025-2030) & (K Units)
Table 93. Europe Nifedipine Controlled-release Tablets Sales Quantity by Country (2019-2024) & (K Units)
Table 94. Europe Nifedipine Controlled-release Tablets Sales Quantity by Country (2025-2030) & (K Units)
Table 95. Europe Nifedipine Controlled-release Tablets Consumption Value by Country (2019-2024) & (USD Million)
Table 96. Europe Nifedipine Controlled-release Tablets Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2024) & (K Units)
Table 98. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Type (2025-2030) & (K Units)
Table 99. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2024) & (K Units)
Table 100. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Application (2025-2030) & (K Units)
Table 101. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Region (2019-2024) & (K Units)
Table 102. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Region (2025-2030) & (K Units)
Table 103. Asia-Pacific Nifedipine Controlled-release Tablets Consumption Value by Region (2019-2024) & (USD Million)
Table 104. Asia-Pacific Nifedipine Controlled-release Tablets Consumption Value by Region (2025-2030) & (USD Million)
Table 105. South America Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2024) & (K Units)
Table 106. South America Nifedipine Controlled-release Tablets Sales Quantity by Type (2025-2030) & (K Units)
Table 107. South America Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2024) & (K Units)
Table 108. South America Nifedipine Controlled-release Tablets Sales Quantity by Application (2025-2030) & (K Units)
Table 109. South America Nifedipine Controlled-release Tablets Sales Quantity by Country (2019-2024) & (K Units)
Table 110. South America Nifedipine Controlled-release Tablets Sales Quantity by Country (2025-2030) & (K Units)
Table 111. South America Nifedipine Controlled-release Tablets Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Nifedipine Controlled-release Tablets Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Type (2019-2024) & (K Units)
Table 114. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Type (2025-2030) & (K Units)
Table 115. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Application (2019-2024) & (K Units)
Table 116. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Application (2025-2030) & (K Units)
Table 117. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Country (2019-2024) & (K Units)
Table 118. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Country (2025-2030) & (K Units)
Table 119. Middle East & Africa Nifedipine Controlled-release Tablets Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Middle East & Africa Nifedipine Controlled-release Tablets Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Nifedipine Controlled-release Tablets Raw Material
Table 122. Key Manufacturers of Nifedipine Controlled-release Tablets Raw Materials
Table 123. Nifedipine Controlled-release Tablets Typical Distributors
Table 124. Nifedipine Controlled-release Tablets Typical Customers
List of Figures
Figure 1. Nifedipine Controlled-release Tablets Picture
Figure 2. Global Nifedipine Controlled-release Tablets Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Nifedipine Controlled-release Tablets Revenue Market Share by Type in 2023
Figure 4. Generic Drug Examples
Figure 5. Original Drug Examples
Figure 6. Global Nifedipine Controlled-release Tablets Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Nifedipine Controlled-release Tablets Revenue Market Share by Application in 2023
Figure 8. Hospital and Clinic Examples
Figure 9. Retail Pharmacies Examples
Figure 10. Other Examples
Figure 11. Global Nifedipine Controlled-release Tablets Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Nifedipine Controlled-release Tablets Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Nifedipine Controlled-release Tablets Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Nifedipine Controlled-release Tablets Price (2019-2030) & (US$/Unit)
Figure 15. Global Nifedipine Controlled-release Tablets Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Nifedipine Controlled-release Tablets Revenue Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Nifedipine Controlled-release Tablets by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 18. Top 3 Nifedipine Controlled-release Tablets Manufacturer (Revenue) Market Share in 2023
Figure 19. Top 6 Nifedipine Controlled-release Tablets Manufacturer (Revenue) Market Share in 2023
Figure 20. Global Nifedipine Controlled-release Tablets Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Nifedipine Controlled-release Tablets Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Nifedipine Controlled-release Tablets Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Nifedipine Controlled-release Tablets Average Price by Type (2019-2030) & (US$/Unit)
Figure 30. Global Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Nifedipine Controlled-release Tablets Revenue Market Share by Application (2019-2030)
Figure 32. Global Nifedipine Controlled-release Tablets Average Price by Application (2019-2030) & (US$/Unit)
Figure 33. North America Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Nifedipine Controlled-release Tablets Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Nifedipine Controlled-release Tablets Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 38. Canada Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 39. Mexico Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 40. Europe Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Nifedipine Controlled-release Tablets Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Nifedipine Controlled-release Tablets Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 45. France Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Nifedipine Controlled-release Tablets Consumption Value Market Share by Region (2019-2030)
Figure 53. China Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 54. Japan Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 55. South Korea Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 56. India Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 57. Southeast Asia Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 58. Australia Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 59. South America Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Nifedipine Controlled-release Tablets Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Nifedipine Controlled-release Tablets Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 64. Argentina Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity Market Share by Country (2019-2030)
Figure 68. Middle East & Africa Nifedipine Controlled-release Tablets Consumption Value Market Share by Country (2019-2030)
Figure 69. Turkey Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 70. Egypt Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 72. South Africa Nifedipine Controlled-release Tablets Consumption Value (2019-2030) & (USD Million)
Figure 73. Nifedipine Controlled-release Tablets Market Drivers
Figure 74. Nifedipine Controlled-release Tablets Market Restraints
Figure 75. Nifedipine Controlled-release Tablets Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Nifedipine Controlled-release Tablets in 2023
Figure 78. Manufacturing Process Analysis of Nifedipine Controlled-release Tablets
Figure 79. Nifedipine Controlled-release Tablets Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
![btl](/_nuxt/img/btl.804ba4b.webp)
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
![tuBiao1](/_nuxt/img/tuBiao1.80a8e3d.webp)
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
![btl](/_nuxt/img/btl.804ba4b.webp)
Companies Mentioned
Bayer Shanghai Shyndec Pharma Simcere Qingdao Baiyang Pharmaceutical China Resources Double Crane Limin Pharmaceutical (Jinan) Hefei Cube Pharma Deyao Pharma Apichope Nanjing EASEHEAL Pharma Beijing Honglin Pharma
Purchase Options
Add To Cart
Buy Now
![masterCard](https://www.globalinforesearch.com/uploads/payment/bot/masterCard.webp)
![visa](https://www.globalinforesearch.com/uploads/payment/bot/visa.webp)
![](https://www.globalinforesearch.com/uploads/payment/bot/discover.webp)
![jcb](https://www.globalinforesearch.com/uploads/payment/bot/jcb.webp)
![](https://www.globalinforesearch.com/uploads/payment/bot/dinersClub.webp)
![americanExpress](https://www.globalinforesearch.com/uploads/payment/bot/americanExpress.webp)
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>